Warfarin, aspirin, and intracranial vascular disease.
Koroshetz
Walter J
WJ
D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications / Q000188:drug therapy*; D002546:Ischemic Attack, Transient / Q000517:prevention & control; D009026:Mortality; D020521:Stroke / Q000517:prevention & control*; D013923:Thromboembolism / Q000175:diagnosis; D017211:Treatment Failure; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014859:Warfarin; D001241:Aspirin